|
|
U.S. Moist Wound Dressings MarketsPublished by: Frost & Sullivan Published: Aug. 30, 2006 Table of Contents1. Executive Summary 2. U.S. Moist Wound Dressings Market 3. U.S. Alginate Dressings Market 4. U.S. Hydrocolloid Dressings Market 5. U.S. Transparent Film Dressings Market 6. U.S. Foam Dressings Market 7. U.S. Hydrogel Dressings Market 8. Appendix AbstractResearch OverviewThis Frost & Sullivan research service entitled U.S. Moist Wound Dressings Markets provides an overview of the effects of limited reimbursement and market consolidation, estimated revenues and market share, along with analysis of key market drivers, restraints, and trends that are impacting manufacturers’ research and development, and healthcare providers’ spending. Market Sectors Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:
Manufacturers of moist wound dressings are increasingly threatened by market acceptance of substitute products, antimicrobial and active dressings. To effectively compete, manufacturers are developing hybrid products by combining existing composites into moist wound dressings or combining several moist wound dressing composites. Innovative advancements including the integration of materials such as collagen, hyaluronic acid, and silver are creating new categories of moist wound dressings and driving growth in this market. In a highly mature market, growth is dependent on differentiating oneself. Advancement in technology has slowed, with only recent innovations revitalizing this market. As the demand rises for more effective wound dressings, manufacturers that are unable to distinguish themselves will likely be forced to exit. However, those manufacturers that are able to penetrate multiple segments or create niche opportunities will garner significant market share. New products are not easily accepted in this market. The healthcare system is increasingly demanding products that provide a superior healing environment, while remaining cost-effective. Since advanced dressings often lack adequate reimbursement coverage, hospitals and patients must absorb the cost, causing them to be hesitant to adopt these dressings. As a result, manufacturers that reinforces their relationships with the healthcare community, providing clinical support and competitive pricing stand apart from other participants. A major factor for the increasing usage of moist wound dressings is the clinical benefits with faster healing rates, reduced scarring and higher absorbency, thereby resulting in an improved outcome for patients. Although moist wound dressings are more expensive than dry gauze, the total cost of treatment using moist wound dressings is reduced by almost 60 percent. Unlike dry and impregnated gauze, moist wound dressings are not changed as frequently, thus reducing high labor costs associated with clinicians who administer the treatment. In turn, adoption of moist wound dressings is steadily increasing, with the treatment transitioning from dry gauze to moist wound dressings. These dressings provide an environment for cell repair, while reducing pain during dressing changes. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||